UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

The Journal of experimental medicine, 2019-12, Vol.216 (12), p.2778-2799

2019

Volltextzugriff (PDF)

In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases

Cell stem cell, 2016-07, Vol.19 (1), p.107-119

2016

Volltextzugriff (PDF)

Identification of novel Pax8 targets in FRTL-5 thyroid cells by gene silencing and expression microarray analysis

PloS one, 2011-09, Vol.6 (9), p.e25162-e25162

2011

Volltextzugriff (PDF)

In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions

Blood advances, 2019-06, Vol.3 (12), p.1916-1924

2019

Volltextzugriff (PDF)

Exploitation of circulating CD34+ cells and non-genotoxic conditioning to overcome major limitations to treatment for autosomal recessive osteopetrosis

Bone Reports, 2020-10, Vol.13, p.100596, Article 100596

2020

Volltextzugriff (PDF)

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential

Biochimica et biophysica acta. Molecular cell research, 2024-12, Vol.1871 (8), p.119818, Article 119818

2024

Volltextzugriff (PDF)

In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells

Science translational medicine, 2015-02, Vol.7 (273), p.273ra13

2015

Volltextzugriff (PDF)

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Blood, 2018-11, Vol.132 (22), p.2362-2374

2018

Volltextzugriff (PDF)

Bayesian networks for cell differentiation process assessment

Stat (International Statistical Institute), 2020, Vol.9 (1), p.n/a

2020

Volltextzugriff (PDF)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Molecular therapy, 2022-10, Vol.30 (10), p.3333-3333

2022

Volltextzugriff (PDF)

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

The Lancet. Haematology, 2019-05, Vol.6 (5), p.e239-e253

2019

Volltextzugriff (PDF)

Adaptive Routes of Hematopoietic Stem Cell Differentiation to Disease Conditions and Age in Gene Therapy Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.1904-1905

2022

Volltextzugriff (PDF)

Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency

Blood, 2021-11, Vol.138 (Supplement 1), p.2937-2937

2021

Volltextzugriff (PDF)

531. Computational Pipeline for the Identification of Integration Sites and Novel Method for the Quantification of Clone Sizes in Clonal Tracking Studies

Molecular therapy, 2016-05, Vol.24, p.S212-S213

2016

Volltextzugriff (PDF)

A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB

Molecular therapy. Methods & clinical development, 2024-09, Vol.32 (3), p.101313, Article 101313

2024

Volltextzugriff (PDF)

Biological Properties of HSC: Scientific Basis for HSCT

The EBMT Handbook, 2018, p.49-56

2018

Volltextzugriff (PDF)

Comprehensive Clonal Mapping of Hematopoiesis in Vivo in Humans By Retroviral Vector Insertional Barcoding

Blood, 2014-12, Vol.124 (21), p.5-5

2014

Volltextzugriff (PDF)

In Vivo Tracking of T Cells in Humans Unveils Decade-Long Survival and Activity of Genetically Modified T Memory Stem Cells

Blood, 2014-12, Vol.124 (21), p.547-547

2014

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

ThemaHematopoietic Stem Cells

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases

Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis

Identification of novel Pax8 targets in FRTL-5 thyroid cells by gene silencing and expression microarray analysis

In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions

S250: UNVEILING THE BIOLOGICAL ROLE OF PERIPHERAL BLOOD HUMAN CIRCULATING HEMATOPOIETIC STEM AND PROGENITOR CELLS

Exploitation of circulating CD34+ cells and non-genotoxic conditioning to overcome major limitations to treatment for autosomal recessive osteopetrosis

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential

In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency

Bayesian networks for cell differentiation process assessment

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Unveiling the Biological Role of Peripheral Blood Human Circulating Hematopoietic Stem and Progenitor Cells

Adaptive Routes of Hematopoietic Stem Cell Differentiation to Disease Conditions and Age in Gene Therapy Patients

Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency

531. Computational Pipeline for the Identification of Integration Sites and Novel Method for the Quantification of Clone Sizes in Clonal Tracking Studies

A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB

Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010

Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency

Biological Properties of HSC: Scientific Basis for HSCT

Comprehensive Clonal Mapping of Hematopoiesis in Vivo in Humans By Retroviral Vector Insertional Barcoding

In Vivo Tracking of T Cells in Humans Unveils Decade-Long Survival and Activity of Genetically Modified T Memory Stem Cells

Aktive Filter

Suchergebnisse filtern